WESTCHESTER COUNTY LIFE SCIENCES UPDATE

Regeneron Founders Plan to Assume Additional Roles

The founders of Tarrytown-based Regeneron, Leonard Schleifer and George Yancopoulos, are expected to become co-chairs of the company’s Board of Directors after the company’s annual meeting on June 9. 

Long-term incumbent Dr. Roy Vagelos will retire from his role as chairman of US biotech Regeneron Pharmaceuticals’ board of directors and will not stand for re-election. Dr. Vagelos has served as chairman since January 1995 and will complete his current term through the conclusion of the Annual Meeting on June 9, 2023.

Teladoc Health Launches Provider-Based Care for Weight Management & Prediabetes Programs

Purchase’s Teladoc Health, the global leader in whole-person virtual care, announced the expansion of Provider-Based Care for weight management and prediabetes programs. Currently available for diabetes and hypertension programs, the addition of Provider-Based Care services for weight management and diabetes prevention is crucial as 42% of adults in the United States today are estimated to live with obesity and 1 in 3 American adults have prediabetes. 

Provider-Based Care delivers a unique and integrated care experience for members, including access to a Teladoc Health physician for a personalized care plan, along with coaching for day-to-day guidance with actionable digital tools. By addressing the full range of cardiometabolic health risk factors associated with obesity, prediabetes, diabetes and hypertension, the company aims to drive better health outcomes for all members.

Cognition Therapeutics to Present Analysis Showing Impact of CT1812 on Pathways Implicated in Dry Age-related Macular Degeneration at ARVO 2023

Purchase’s Cognition Therapeutics, Inc. will be presenting in vitro results characterizing the role of sigma-2 (σ-2) receptors and effect of CT1812 in cell-based models of dry age-related macular degeneration (AMD). CT1812 is an experimental orally delivered, small molecule drug candidate that binds to σ-2 receptors, which have been shown to regulate key cellular processes involved in age-related degenerative diseases.

WCBA Cohort Member Wins Third Place in

Millard Chan Technology Challenge

Neetika Ashwani, MPH, a member of the Westchester County Biosciences Accelerator's 2023 cohort, recently won third place at the Columbia Venture Competition's Millard Chan Technology Challenge. Her venture, KRIASH, is a wearable device that keeps track of vitals (heart rate, respiratory rate, saturation, temperature) and contact duration in newborns to reduce neonatal morbidity and mortality.

WCBA Cohort Member Launches Boutique Fertility Consultancy

Justine Witzke, a member of the Westchester County Biosciences Accelerator's 2023 cohort, has launched Aligneage Fertility, a boutique, human-centered sperm bank and fertility consultancy. The mission of Aligneage Fertility is to provide high-quality, equitably accessible, compassionate, personalized, and evidence-based andrology services, sperm donor screening procedures, fertility guidance, and industry-specific consulting. 

Patient consultations and educational seminars as well as staff training and business-to-business consulting are available now, and laboratory and clinical services are expected to be available Summer 2023.

Learn more and stay up to date by visiting their website and following them on Instagram @aligneagefertility. 

Justine will be presenting live at the WCBA's Pitch Day on May 11. Click here for more information.

UPCOMING EVENTS

ABCT | WCBA: Pitch Day 2023

This annual event features pitches and presentations from 23 ventures from both the ABCT and WCBA life sciences accelerator programs. This year's event will also feature a panel of distinguished alums who will share their work changing care within biosciences.

Date: Thursday, May 11, 2023

Time: 1:00 PM – 6:00 PM

Register

Have good news to share with

Westchester’s life sciences ecosystem?

Please let us know.

Email lifesciences@westchestergov.com.